Irene Arroyo, DPM
Primary Podiatric Medicine · Dallas, TXNPI 1083053565
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,720 of the $10,821 with a category attached, or 71.3%. Pylant Medical accounts for 71.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2022 at $3,837 and has fallen 59.7% since, to $1,548 in 2025. Among primary podiatric medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $174.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$8K
- Endo USA, Inc.$653
- Medline Industries LP$378
- Stryker$338
- Smith+Nephew$265
- Integra Lifesciences Corporation$258
- plus $1K from 15 others
What the payments were for
- Travel & lodging$5095%
- Food & beverage$2,59124%
- Education$7,72071%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 10 | $7,732 |
| Endo USA, Inc. | 6 | $653 |
| Medline Industries LP | 3 | $378 |
| Stryker | 9 | $338 |
| Smith+Nephew | 11 | $265 |
| Integra Lifesciences Corporation | 1 | $258 |
| Medtronic | 3 | $188 |
| Kerecis Limited | 1 | $162 |
| Osteoremedies, LLC | 1 | $153 |
| Bone Support Inc. | 1 | $150 |
| Polynovo North America LLC | 2 | $129 |
| Vertex | 1 | $125 |
| Johnson & Johnson | 2 | $69 |
| Orthofix Medical, Inc. | 3 | $43 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $42 |
| Ossur Americas, Inc. | 1 | $33 |
| Organogenesis Inc. | 1 | $27 |
| Extremity Medical | 1 | $23 |
| Nevro Corp. | 1 | $21 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $18 |
| Globus Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,821 in reported general payments places this provider in the 90th percentile of 36 primary podiatric medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 63 | $1,760 |
| Ketoconazole | 40 | $1,187 |
| Ciclopirox | 20 | $658 |
| Doxycycline Hyclate | 44 | $520 |
| Mupirocin | 40 | $285 |
| Gabapentin | 11 | $255 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $119 |
| Meloxicam | 34 | $86 |
| Methylprednisolone | 12 | $64 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Dallas
- Harry YankunerDallas$249
- Kenneth WilliamsSan Antonio$26K
- Tomas TrevinoEl Campo$17K
- Fernando FernandezThe Woodlands$7K
- Susie Sant'annaFredericksburg$7K
- Silas SalanoArlington$6K
- Christian MorrisonMurphy$6K
- Barton GarciaShenandoah$5K
- Eric HigginsDumas$3K
- Maureen CaldwellVictoria$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.